NCT02709018: A reported trial by University of California, San Diego
This trial has reported on time, in line with the regulations.
Full data
| Full entry on ClinicalTrials.gov | NCT02709018 |
|---|---|
| Title | Enhancing Fear Extinction Via Angiotensin Type 1 Receptor Inhibition: A Randomized Controlled Trial in Posttraumatic Stress Disorder |
| Results Status | Reported |
| ACT or pACT? | This is what FDAAA officially calls a "probable Applicable Clinical Trial" |
| Start date | July 16, 2016 |
| Completion date | Feb. 29, 2020 |
| Required reporting date | Feb. 28, 2021, midnight |
| Actual reporting date | Feb. 2, 2021 |
| Date last checked at ClinicalTrials.gov | March 28, 2025 |
| Days late | None |